Solutions and suspensions are increasingly prevalent in pharmaceuticals, across a wide array of dosage forms. However, maintaining active pharmaceutical ingredient (API) distribution in liquids while retaining other properties, such as the desired viscosity, can be a challenge with these formulations. Selecting optimal pharmaceutical excipients and an experienced and comprehensive development and manufacturing partner is essential to your success.
Our
Carbopol® polymers and
Noveon® polycarbophil are ideal for achieving the desired properties of your pharmaceutical solution or pharmaceutical suspension. These excipients have been successfully used in numerous commercial products for
topical,
oral liquid, and
transdermal applications. We partner with our customers, offering processing and formulation support to expedite your product to market.
Benefits of our polymers include:
- Highly efficient rheology modification at low usage levels
- Ideal flowability for sprayed, pumped, spread, and poured formulations
- High yield value and efficient microgel formation allows, providing stable, robust suspensions
- Bioavailability enhancement via excellent mucoadhesive properties
- Taste masking for increased patient compliance in oral liquid applications
- Temperature resistance with minimal effect on viscosity
Our excipients are manufactured under GMPs in ISO:9001 certified facilities, have established DMFs, and have been extensively tested for biocompatibility and safety.
Technical Solutions
All LLS Health products and services are supported by a knowledgeable Technical Solutions staff and technical centers around the world dedicated to aiding our clients.
CDMO Services
Our
CDMO Division provides a suite of services and novel technologies for solutions and suspensions across any dosage form, both sterile and non-sterile. We provide excellence in execution and have the infrastructure and capabilities to explore numerous topical and mucosal formats while offering a low-risk pathway to clinic for even the most complex products.
